Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Internal Medicine)
Dermatologist
M.B.B.S, M.R.C.P (UK)
Consultant Physician
MBBS, M.D Gastroenterology (Gold Medalist), FRCP (Gastroenterology & General Medicine)
Consultant Physician
MBBS, M.D Gastroenterology (Gold Medalist), FRCP (Gastroenterology & General Medicine)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
Certified in Diabetology (USA), F.C.P.S (Medicine), M.B.B.S
Internal Medicine Specialist
Certified in Diabetology (USA), F.C.P.S (Medicine), M.B.B.S
Diabetologist
M.B.B.S, MRCGP, CDE (Certified Diabetes Educator), MCCEE
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Gastroenterologist
MBBS, Member of Royal College of Physicians (MRCP), (FCPS) Gastroenterology
Gastroenterologist
MBBS, Member of Royal College of Physicians (MRCP), (FCPS) Gastroenterology
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures